Spero Therapeutics
SPRO
SPRO
61 hedge funds and large institutions have $122M invested in Spero Therapeutics in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more capital invested
Capital invested by funds: $119M → $122M (+$3.78M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
61
Holding in Top 10
2
Calls
–
Puts
$1K
Top Buyers
| 1 | +$5.51M | |
| 2 | +$5.36M | |
| 3 | +$2.71M | |
| 4 |
Renaissance Technologies
New York
|
+$1.17M |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$1.15M |
Top Sellers
| 1 | -$1.84M | |
| 2 | -$819K | |
| 3 | -$691K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$490K |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$186K |